CTS Corp Provides FY2026 Guidance and Highlights Diversified Market Growth in Investor Presentation
CTS sits 63% above its 52-week low of $34.02.
Summary
CTS Corp released an investor presentation detailing strong FY2025 results and providing positive FY2026 guidance, emphasizing growth in diversified markets.
Key Events · Earnings and Guidance · CTS
-
FY2025 Performance
Reported LTM (Last Twelve Months) revenue of $541 million and adjusted diluted EPS of $2.23 as of December 2025.
-
FY2026 Guidance
Projected revenue between $550 million and $580 million, and adjusted diluted EPS between $2.30 and $2.45 for fiscal year 2026.
-
Diversified Market Growth
Highlighted a 10% CAGR in diversified end markets (industrial, aerospace & defense, medical) from 2019-2025, now representing 57% of total revenue.
-
Strategic Outlook
Emphasized a long-term target of 10% CAGR, driven by organic and inorganic growth, and strategic M&A.
Analysis · CTS · Manufacturing
The filing details CTS Corp's financial performance for the fiscal year ended December 31, 2025, and provides positive guidance for fiscal year 2026. The company expects continued revenue and adjusted diluted EPS growth, driven by its diversified end markets, despite anticipated softness in commercial vehicle sales and flat light vehicle production. This outlook reinforces the company's strategic shift towards high-growth sectors and its ability to deliver consistent performance, supporting its current trading near 52-week highs.
At the time of this filing, CTS was trading at $55.58 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $34.02 to $56.15. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.